1. Polymorphic hydroxylation of debrisoquine in man;Mahgoub, A.; Idle, JR, Dring; LG, Lancaster; R, Smith; R.L.;Lancet,1977
2. Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment;Brosen, K.; Gram, L.F.; Haghfelt, T.; Bertilsson, L.;Pharmacol Toxicol,1987
3. Aetiology of Parkinson's disease;Calne, D.B.; Langston, J.W.;Lancet,1983
4. A family and population study of the genetic polymorphism of debrisoquine in a white British population;Evans, D.A.P.; Mahgoub, A.; Sloan, T.P.; Idle, JR, Smith; R.L.;J Med Genet,1980
5. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase;Chiba, K.; Trevor, A.; Castagnoli, N.;Biochem Biophys Res Commun,1984